Results 161 to 170 of about 19,199 (220)

Impact of concomitant fibromyalgia on disease activity assessment and quality of life in Vietnamese patients with rheumatoid arthritis. [PDF]

Rheumatol Adv Pract
Thi NT, Thi HD, Thi HV, Thi Phuong TN.
europepmc   +1 more source

Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial. [PDF]

EClinicalMedicine
Tas SW, Christiaans J, Boumans MJH, Koopman FA, Pickrell P, Goddard DH, Kivitz A, Patel-Banker M, Chu CQ, Lee E, Wickersham P, Alli VV, Faulkenberry TL, Jenkins M, Winder J, Luyer MDP, Barnett C, Famm K, Irwin E, Kwong K, Scribner LL, Milliken PH, Raji O, Rall K, Sokal DM, Whiteman H, Mahmood A, Vervoordeldonk MJ, Gupta I, Abdulai RM, Broen JCA.   +30 more
europepmc   +1 more source

Real-world effectiveness of tofacitinib in monotherapy or in combination with csDMARDs in patients with rheumatoid arthritis: A collaboration between Dutch registries (TOFADUDAP study). [PDF]

Clin Rheumatol
Nevins IS, Glas HK, Reimann F, Bos R, de Buck MPD, Drossaers-Bakker KW, Hegeman MC, Huizinga TWJ, Bergstra SA.   +8 more
europepmc   +1 more source

Association Between Fish Consumption and Minimal Disease Activity in Patients With Rheumatoid Arthritis Receiving Molecular-Targeted Therapies. [PDF]

Int J Rheum Dis
Tarumi M, Amengual O, Navidad M, Oki Y, Yasuda M, Kosumi Y, Takeyama S, Yoshimura M, Ninagawa K, Aso K, Hisada R, Nakamura H, Kono M, Fujieda Y, Kato M, Nakamura A, Kumagai S, Cáliz R, Atsumi T.   +18 more
europepmc   +1 more source

Author Correction: A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis. [PDF]

Nat Commun
He S, Zhu C, Liu Y, Xu Z, Sun R, Yang B, Guo X, Herrmann I M, Muñoz LE, Gjertsson I, Holmdahl R, Dai L, Zhao Y.   +12 more
europepmc   +1 more source

Subcutaneous methotrexate compared with oral methotrexate in rheumatoid arthritis: a systematic review and meta-analysis. [PDF]

Front Immunol
Li G, Xie W, Liu J, Geng Y, Zhang Z.
europepmc   +1 more source

Glucocorticoid-Sparing Effect of Biologic Therapy in Rheumatoid Arthritis: A Single-Center Longitudinal Observational Study Comparing Rituximab With Tumor Necrosis Factor Inhibitors. [PDF]

Cureus
Ben Marzouk I, El Binoune I, Rostom S, El Moubarik I, Zemrani S, Amine B, Dib K, Bahiri R.   +7 more
europepmc   +1 more source

Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis. [PDF]

RMD Open
Karpouzas GA, Gonzalez-Gay MA, Pascual-Ramos V, Misra DP, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Galarza-Delgado D, Van Riel P, Semb AG, Hauge EM, Kitas GD, Ormseth SR, for An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).   +15 more
europepmc   +1 more source

From Concurrent Response Tracking to Clinically Actionable Biomarkers in Rheumatoid Arthritis: Comment on Jhou et al. [PDF]

Int J Rheum Dis
Ying Y, Wang X.
europepmc   +1 more source

Baseline body mass index and early functional recovery after first recorded advanced therapy in rheumatoid arthritis: a real-world cohort study. [PDF]

Rheumatol Int
Tatar OD, Kılıç L, Kalyoncu U, Ertenli AI.   +3 more
europepmc   +1 more source